| Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and … G Chana, L Laskaris, C Pantelis, P Gillett, R Testa, D Zantomio, ... Brain, behavior, and immunity 49, 197-205, 2015 | 60 | 2015 |
| Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis G Chana, CA Bousman, TT Money, A Gibbons, P Gillett, B Dean, ... Frontiers in cellular neuroscience 7, 95, 2013 | 47 | 2013 |
| MicroRNA Dysregulation in Schizophrenia and Functional Consequences L Laskaris, TT Lee, P Gillett, G Chana Mapping of Nervous System Diseases via MicroRNAs, 59-99, 2016 | 1 | 2016 |
| Construction of a genetic classifier for ASD using gene pathway analysis G Chana, R Testa, P Gillett, D Williams, CA Bousman, D Zantomio, ... Frontiers in Autism Research: New Horizons for Diagnosis and Treatment, 119-143, 2014 | 1 | 2014 |
| Assessing neuro-oncology clinical trial impact and value: Testing a novel multi-criteria decision analysis app KM Field, MA Rosenthal, P Gillett, M IJzerman Journal of Clinical Neuroscience 118, 70-78, 2023 | | 2023 |
| Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value P Gillett, RK Mahar, NR Tran, M Rosenthal, M IJzerman Cost Effectiveness and Resource Allocation 21 (1), 87, 2023 | | 2023 |
| Quantifying the Travel Undertaken by Cancer Patients Receiving Radiotherapy in Victoria, Australia P Gillett, F Franchini, K Trapani, PK Tran, D Herath, K Donohoe, F Foroudi, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), e585, 2023 | | 2023 |
| 1687O PRIMCAT: A novel approach to informing health technology assessment decision making in Australia F Franchini, K Trapani, J Soon, B Daniels, P Gillett, K Degeling, ... Annals of Oncology 34, S924, 2023 | | 2023 |
| Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials P Gillett, RK Mahar, NR Tran, M Rosenthal, M IJzerman medRxiv, 2022.12. 07.22283233, 2022 | | 2022 |
| The PRIMCAT cohort study: Analysis of treatment utilisation, costs, and outcomes in Victoria for patients with cancer F Franchini, K Trapani, P Gillett, K Degeling, B Daniels, S Pearson, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18, 180-181, 2022 | | 2022 |
| 3 MicroRNA Dysregulation L Laskaris, TT Lee, P Gillett, G Chana Mapping of Nervous System Diseases via MicroRNAs, 59, 2016 | | 2016 |
